(Medical Xpress)—For the first time, scientists at the UNC School of Medicine have shown that eliminating the enzyme factor XIII reduces the number of red blood cells trapped in a clot, resulting in a 50 percent reduction ...
Jul 3, 2014
0
0
Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics ...
Jun 17, 2014
0
0
In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, ...
Jun 17, 2014
0
0
Air pollution is linked to an increased risk of developing an irregular heartbeat—a risk factor for stroke—and blood clots in the lung, finds a large study published online in the journal Heart.
Jun 4, 2014
0
0
(HealthDay)—A single intravenous bolus of tenecteplase reduces early death and hemodynamic decompensation in normotensive patients with intermediate-risk pulmonary embolism, but increases the risk of major hemorrhage and ...
Apr 11, 2014
0
0
Using a patient's age to raise the threshold for an abnormal result of a blood test used to assess patients with a suspected pulmonary embolism (blood clot in lungs) appeared to be safe and led to fewer healthy patients with ...
Mar 18, 2014
0
0
In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor ...
Feb 5, 2014
0
0
(HealthDay)—The risk of death from hip- or knee-replacement surgery has dropped substantially in recent years, a large new study finds.
Jan 9, 2014
0
0
(HealthDay)—The top five pulmonology-related issues that physicians and patients should question have been released by the American College of Chest Physicians and American Thoracic Society (ATS) as part of the Choosing ...
Oct 29, 2013
0
0
In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin ...
Sep 1, 2013
0
0
